Cardiology Today's top 5 stories in May
Click Here to Manage Email Alerts
Cardiology Today has compiled a list of the top 5 articles posted to Healio.com/Cardiology in May.
This month, our readers were most interested in the effects of protein consumption on HF risk, common mistakes in BP measurement, knowledge gaps in dietary education and training, the results of the NAVIGATE and CABANA trials and much more.
Protein intake may increase HF risk in men
Men who were middle aged and followed a diet with a higher protein intake had a trend toward increased risk for HF, according to a study published in Circulation: Heart Failure.
“As many people seem to take the health benefits of high-protein diets for granted, it is important to make clear the possible risks and benefits of these diets,” Jyrki Virtanen, PhD, adjunct professor of nutritional epidemiology at the University of Eastern Finland in Kuopio, said in a press release. “Earlier studies had linked diets high in protein — especially from animal sources — with increased risks of type 2 diabetes and even death.”
7 common mistakes in BP measurement
The American Heart Association has named May National High Blood Pressure Education month.
According to a press release from the AHA, mistakes are often made in home or office BP tests, which may lead to inaccurate readings. Clinicians and patients can avoid inaccurate BP readings by looking for seven common pitfalls.
Knowledge gaps remain in dietary education, training
Unhealthy dietary patterns remain a major contributor to massive public health and economic burden despite existing knowledge that diet quality significantly affects atherosclerotic CVD, according to a science advisory from the American Heart Association published in Circulation.
NAVIGATE ESUS: Rivaroxaban fails to reduce recurrence in embolic stroke
Rivaroxaban did not reduce the risk for recurrent stroke in patients with embolic stroke compared with aspirin, although it increased the risk for bleeding, according to data presented at the European Stroke Organization Conference.
The results were simultaneously published in The New England Journal of Medicine.
CABANA: Ablation an ‘acceptable treatment strategy’ for AF
BOSTON — In patients with atrial fibrillation, catheter ablation conferred better outcomes compared with drug therapy in on-treatment and per-protocol analyses, but not in an intention-to-treat analysis, according to the results of the CABANA trial.
The difference in analyses was attributed to nearly 30% of patients assigned to drug therapy eventually receiving ablation, and nearly 10% of patients assigned to ablation not undergoing the procedure, Douglas L. Packer, MD, professor of medicine and consultant in the division of heart rhythm services, department of cardiovascular medicine, Mayo Clinic, said during a presentation at the Heart Rhythm Society Annual Scientific Sessions.